Haqq Christopher - SEC Form 4 Insider Trading Screener
19 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 18 | +2 | +2 | +3 | -29 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2017-05-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $14.99 | -7,604 | 394,080 | -2% | -$113,984 | |||||
2017-04-17 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $17.28 | -6,000 | 400,855 | -1% | -$103,680 | +2 | -5 | ||||
2017-03-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $19.60 | -6,000 | 406,855 | -1% | -$117,600 | +6 | +5 | -13 | |||
| D | 2017-02-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $15.49 | -7,604 | 412,855 | -2% | -$117,786 | 0 | -5 | +28 | ||
2017-02-09 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $15.46 | -13,975 | 419,630 | -3% | -$216,054 | +1 | +3 | +48 | |||
2017-01-17 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $14.27 | -6,000 | 384,105 | -2% | -$85,620 | -4 | -7 | +10 | |||
2016-12-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $15.40 | -6,000 | 390,105 | -2% | -$92,400 | +1 | -3 | -12 | |||
2016-11-21 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $17.85 | -7,068 | 396,105 | -2% | -$126,164 | +6 | +12 | -15 | |||
| D | 2016-11-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $19.95 | -1,604 | 403,173 | 0% | -$32,000 | -2 | +6 | -12 | ||
| D | 2016-08-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $22.32 | -1,346 | 313,948 | 0% | -$30,041 | +2 | 0 | -14 | -28 | |
| D | 2016-05-16 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $15.57 | -1,605 | 314,465 | -1% | -$24,990 | 0 | +10 | +27 | +27 | |
| D | 2016-02-16 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $15.43 | -3,208 | 315,240 | -1% | -$49,499 | +3 | -5 | -2 | +36 | |
2015-08-31 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $41.99 | -5,000 | 260,890 | -2% | -$209,961 | +11 | +12 | -19 | -48 | ||
| D | 2015-08-17 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $45.91 | -1,604 | 265,890 | -1% | -$73,632 | -9 | -14 | +4 | -63 | |
2015-07-31 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $55.43 | -2,500 | 266,665 | -1% | -$138,575 | 0 | -9 | -29 | -67 | ||
2015-07-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $62.94 | -2,500 | 269,165 | -1% | -$157,353 | -1 | -4 | -17 | -65 | ||
2015-07-01 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $51.68 | -2,500 | 271,665 | -1% | -$129,196 | +4 | +17 | +23 | -45 | ||
2015-06-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $46.42 | -7,500 | 274,165 | -3% | -$348,116 | +7 | +4 | +18 | -34 | ||
2015-06-01 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $41.47 | -2,500 | 281,665 | -1% | -$103,665 | +2 | +11 | +26 | -5 |
Custom reports? Email alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |